Carla was appointed as the Director of the Office of Research Development in 2016. Previously, Carla served as Assistant Director for Research Development within the Hollings Cancer Center for several years and supported the center’s National Cancer Institute redesignation in 2014. She has a strong record of leadership, achievement, and innovation in managing the submission of large-scale, multi-investigator grants.
As Assistant Director in the Office of Research Development, Wanda Hutto Pierce supports the research enterprise at MUSC. She is responsible for catalyzing and fostering new funding strategies through foundations and non-NIH agencies; manages the limited submission grant proposal process; content manager and creator for the research newsletter and blog.
Kimberly is the Lead Advisor for Research Training and Outreach Initiatives in the Office of Research Development. Since October 2017, Dr. Cannady has contributed her scientific knowledge and administrative experience to provide consultative services to faculty and staff for grant development and coordinated institutional grant-related activities. She is trained as a biological chemist with an emphasis in biochemical and biophysical characterizations of protein-protein and protein-DNA interactions. Previously, she served as the Community Health Educator at Hollings Cancer Center responsible for establishing and facilitating statewide community partnerships to support, expand, and sustain the HCC’s efforts to address cancer disparities. In addition, she has helped to develop successful training and education grants at MUSC. Dr. Cannady’s hybrid skillset further strengthens the repertoire of services offered within the Office of Research Development to help it evolve and meet the needs of the MUSC Community.
Danielle Hutchison joined the ORD team as a Grants Development Strategist. She will help identify strategic funding opportunities and assist in the development of multi-component and training grant proposals. In a previous role with MUSC’s COBRE in Stroke Recovery, Danielle facilitated the design and implementation of an Evaluation Plan, managed center recruitment and retention efforts and helped coordinate a variety of meetings and mentoring activities.
Alexis Nagel, Ph.D. is a biological chemist by training, and contributes her talents and insight from the research lab to the coordination of grant-related activities and consultation with faculty and staff. Dr. Nagel spent 6 years developing mass spectrometry-based methods for the discovery and characterization of new anticancer drugs and molecular targets relevant to diabetes-associated osteoporosis. Beyond the bench, her expertise includes teaching, project management, and scientific technical writing with a heavy emphasis on pre-award proposal preparation.